Overview

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

Status:
Completed
Trial end date:
2017-06-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of vortioxetine (10 and 20 mg, once daily) versus paroxetine (20 mg, once daily) on sexual functioning in healthy participants after 5 weeks of double-blind treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Paroxetine
Vortioxetine